These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 3100466)

  • 21. Alteration of hormone levels in normal males given the anabolic steroid stanozolol.
    Small M; Beastall GH; Semple CG; Cowan RA; Forbes CD
    Clin Endocrinol (Oxf); 1984 Jul; 21(1):49-55. PubMed ID: 6430603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex hormone-binding globulin response to the anabolic steroid stanozolol: evidence for its suitability as a biological androgen sensitivity test.
    Sinnecker G; Köhler S
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1195-200. PubMed ID: 2723028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treadmill exercise training prevents myocardial mechanical dysfunction induced by androgenic-anabolic steroid treatment in rats.
    Bocalini DS; Beutel A; Bergamaschi CT; Tucci PJ; Campos RR
    PLoS One; 2014; 9(2):e87106. PubMed ID: 24533053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stanazolol--an anabolic steroid that does not influence parathyroid hormone response to hypercalcemia in postmenopausal women.
    Zofková I; Röjdmark S; Kancheva RL
    Calcif Tissue Int; 1994 Jun; 54(6):521-2. PubMed ID: 8082059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of short-term treatment with an anabolic steroid (methandienone) and dehydroepiandrosterone sulphate on plasma hormones, red cell volume and 2,3-diphosphoglycerate in athletes.
    Remes K; Vuopio P; Järvinen M; Härkönen M; Adlercreutz H
    Scand J Clin Lab Invest; 1977 Nov; 37(7):577-86. PubMed ID: 145651
    [No Abstract]   [Full Text] [Related]  

  • 26. Anabolic steroid effects on immune function: differences between analogues.
    Mendenhall CL; Grossman CJ; Roselle GA; Hertelendy Z; Ghosn SJ; Lamping K; Martin K
    J Steroid Biochem Mol Biol; 1990 Sep; 37(1):71-6. PubMed ID: 2242353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. American Academy of Dermatology 1998 Awards for Young Investigators in Dermatology. The anabolic steroid stanozolol upregulates collagen synthesis through the action of transforming growth factor-beta1.
    Falabella AF
    J Am Acad Dermatol; 1998 Aug; 39(2 Pt 1):272-3. PubMed ID: 9704843
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term chronic treatment with stanozolol lacks significant effects on aggression and activity in young and adult male laboratory mice.
    Martínez-Sanchis S; Brain PF; Salvador A; Simón VM
    Gen Pharmacol; 1996 Mar; 27(2):293-8. PubMed ID: 8919645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response of human skeletal muscle to the anabolic steroid stanozolol.
    Hosegood JL; Franks AJ
    BMJ; 1988 Oct; 297(6655):1028-9. PubMed ID: 3142598
    [No Abstract]   [Full Text] [Related]  

  • 30. Anabolic steroid effects on body composition in normal young men.
    Casner SW; Early RG; Carlson BR
    J Sports Med Phys Fitness; 1971 Jun; 11(2):98-103. PubMed ID: 5098429
    [No Abstract]   [Full Text] [Related]  

  • 31. The effects of red blood cell infusion on 10-km race time.
    Brien AJ; Simon TL
    JAMA; 1987 May 22-29; 257(20):2761-5. PubMed ID: 3573270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood doping and related issues: a brief review.
    Gledhill N
    Med Sci Sports Exerc; 1982; 14(3):183-9. PubMed ID: 7109883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of nandrolondecanoate on the pituitary-gonadal axis in males.
    Bijlsma JW; Duursma SA; Thijssen JH; Huber O
    Acta Endocrinol (Copenh); 1982 Sep; 101(1):108-12. PubMed ID: 6812344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unmodified performance in runners following anabolic steroid administration.
    Ballarin E; Guglielmini C; Martinelli S; Casoni I; Borsetto C; Ziglio PG; Conconi F
    Int J Sports Med; 1986 Dec; 7(6):302-6. PubMed ID: 3100466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response of serum hormones to androgen administration in power athletes.
    Alén M; Reinilä M; Vihko R
    Med Sci Sports Exerc; 1985 Jun; 17(3):354-9. PubMed ID: 2991700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Low-dose desmopressin (DDAVP) and blood levels of FSH, LH and testosterone in men].
    García-Pascual IJ; Rozán Flores MA
    Rev Clin Esp; 1996 Mar; 196(3):167-70. PubMed ID: 8650386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pituitary and testicular response to luteinizing hormone releasing hormone in normal and sulpiride-induced hyperprolactinaemic men.
    Nakano R; Yagi S; Nishi T
    Exp Clin Endocrinol; 1988 May; 91(2):191-6. PubMed ID: 3137082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pituitary and gonadal endocrine effects and pharmacokinetics of the novel luteinizing hormone-releasing hormone antagonist teverelix in healthy men--a first-dose-in-humans study.
    Erb K; Pechstein B; Schueler A; Engel J; Hermann R
    Clin Pharmacol Ther; 2000 Jun; 67(6):660-9. PubMed ID: 10872648
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.